DEVELOPMENT AND VALIDATION OF THE RP-HPLC METHOD FOR ESTIMATION OF CILNIDIPINE IN RAT PLASMA
Keywords:RP HPLC, Cilnidipine, Rat plasma, Development, Validation
Objective: A simple, precise, accurate, robust, and reliable RP-HPLC technique for detecting cilnidipine in Wistar rat plasma was developed and validated.
Methods: The chromatographic separation was performed using the C-18 reverse phase column Oyster BDS Premium C18 column (4.6 × 150 mm, 5 µm particle size). The flow rate was set to 1.2 mL/min, and the chromatogram was recorded at 240 nm. The proposed method was validated in compliance with the International Conference on Harmonization (ICH) guidelines.
Results: The calibration curves plotted were found to be linear over the concentration range of 40-200 ng/mL in Wistar rat plasma, with a regression coefficient of R2 > 0.999, suggesting that the linearity was within limits. The LOD and LOQ of the present method were found to be 2.184 and 4.518 ng/mL respectively. Drug extraction recoveries from Wistar rat plasma were found to be > 98%.
Conclusion: Using Wistar rat plasma, a simple, fast, specific, accurate, precise analytical approach was developed and validated. The technique was validated according to the ICH guidelines. The obtained results show that the suggested technique can be simply and effectively utilized for routine cilnidipine analysis in Wistar rat plasma.
Lee KR, Chae YJ, Lee JH, Kim DD, Chong S, Shim CK, et al. Quantification of cilnidipine in human plasma by liquid chromatography-mass spectrometry. Journal of Liquid Chromatography and Related Technologies. 2012;35(2):308–20.
Pawar VT, Pawar SV, More HN, Kulkarni AS, Gaikwad DT. RP-HPLC method for simultaneous estimation of cilnidipine and chlorthalidone. Research Journal of Pharmacy and Technology. 2017;10(11):3990-3996.
Andhale SM, Nikalje AG. Simultaneous estimation of azilsartan and cilnidipine in bulk by RP-HPLC and assessment of its applicability in marketed tablet dosage form. International Journal of Applied Pharmaceutics. 2022;14(1):116–23.
Ghante MR, Akhade A, Gota P, Nikam A, Jagtap S, Nikam V. Development and validation of high-performance thin-layer chromatography method for simultaneous estimation of nebivolol hydrochloride and cilnidipine. Asian Journal of Pharmaceutical and Clinical Research. 2019;12(4):347–50. doi: 10.22159/ajpcr.2019.v12i4.30569.
Zhang X, Zhai S, Zhao R, Ouyang J, Li X, Baeyens WG. Determination of cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectrometric detection. Analytica Chimica Acta. 2007;600(1):142–6.
Manoranjani M. Assay method development and validation of cilnidipine and ramipril, characterization of its degradants by using LC-MS/MS. International Journal of Applied Pharmaceutics. 2022;14(2):276–85.
Diwan R, Ravi PR, Pathare NS, Aggarwal V. Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. Colloids and Surfaces B: Biointerfaces. 2020;193:1-10. doi: 10.1016/j.colsurfb.2020.111073.
Diwan R, Ravi PR, Agarwal SI, Aggarwal V. Cilnidipine loaded poly (ε-caprolactone) nanoparticles for enhanced oral delivery: optimization using DoE, physical characterization, pharmacokinetic, and pharmacodynamic evaluation. Pharmaceutical Development and Technology. 2021;26(3):278–90.
Pawar VT, Pawar SV, More HN, Kulkarni AS, Gaikwad DT. RP-HPLC method for simultaneous estimation of cilnidipine and chlorthalidone. Research Journal of Pharmacy and Technology. 2017;10(11):3990.
Shaikh F, Patel M, Shelke S, Patel V, Jani D, Shinde G, et al. Formulation, characterization, optimization, and pharmacokinetic evaluation of cilnidipine-loaded liquisolid compacts with improved dissolution and bioavailability. Journal of Pharmaceutical Innovation. 2022;17(2):1-22. doi: 10.1007/s12247-022-09651-z.
Sojitra RG, Chotaliya UJ. Analytical method development and validation for simultaneous estimation of fimasartan potassium trihydrate and cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II. Future Journal of Pharmaceutical Sciences. 2021;7(1):1-7.
Remya PN, Damodharan N. Formulation, development, and characterisation of cilnidipine loaded solid lipid nanoparticles. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(9):120–5.
Rathod RH, Patil AS, Shirkhedkar AA. Novel NP and RP-HPTLC in praxis for simultaneous estimation of chlorthalidone and cilnidipine in bulk and pharmaceutical formulation. Analytical Chemistry Letters. 2018;8(6):862–71.
Rupareliya RH, Joshi HS, Ram VR, Dave PN, Khosla E. Stability indicating simultaneous validation of telmisartan and cilnidipine with forced degradation behavior study by RP-UPLC in tablet dosage form. International Journal of Pharmaceutical Quality Assurance. 2016;7(3):39–45.
Lee KR, Chae YJ, Lee JH, Kim DD, Chong S, Shim CK, et al. Quantification of cilnidipine in human plasma by liquid chromatography-mass spectrometry. Journal of Liquid Chromatography & Related Technologies. 2012;35(2):308–20.
Chaudhari SR, Shirkhedkar AA. An investigative review for pharmaceutical analysis of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative: cilnidipine. Critical Reviews in Analytical Chemistry. 2021;51(3):268–77. doi: 10.1080/10408347.2020.1718483, PMID 32048875.
Dalvi AV, Uppuluri CT, Bommireddy EP, Ravi PR. Design of experiments-based RP – HPLC bioanalytical method development for estimation of rufinamide in rat plasma and brain and its application in pharmacokinetic study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2018;1102:74–82.
Tiwari B, Shirsat MK, Kulkarni A. Development and validation of stability indicating RP-HPLC method for estimation of cilnidipine. Journal of Drug Delivery and Therapeutics. 2020;10(1):97–100.
Satyavert, Gupta S, Nair AB, Attimarad M. Development and validation of bioanalytical method for the determination of hydrazinocurcumin in rat plasma and organs by HPLC-UV. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2020;1156:1-8. doi: 10.1016/j.jchromb.2020.122310.
Reddy BK, Sekhar KC, Mohan CK. Bioanalytical method development and validation for the simultaneous determination of vildagliptin and telmisartan in rabbit plasma using RP-HPLC. Journal of Pharmaceutical Research International. 2021;33(1):76–86. doi: 10.9734/jpri/2021/v33i131141.
Siva Prasad S, Rao Anna V, Babu Kasimala B. Quality by design (QBD) based development and validation of an HPLC method for the estimation of lurasidone in pharmaceutical formulations. Journal of Critical Reviews. 2020;18(7):2155-2161.
Maljuric N, Otasevic B, Golubovic J, Krmar J, Zecevic M, Protic A. A new strategy for development of eco-friendly RP-HPLC method using corona charged aerosol detector and its application for simultaneous analysis of risperidone and its related impurities. Microchemical Journal. 2020;153:1-9.
Sabhyatha TS, Babu N. Analytical method validation of gliclazide related substances by high performance liquid chromatography method. International Journal of Current Pharmaceutical Research. 2022;4(14):36–41. doi: 10.22159/ijcpr.2022v14i4.1999.
Khosa A, Krishna KV, Saha RN, Dubey SK, Reddi S. A simplified and sensitive validated RP-HPLC method for determination of temozolomide in rat plasma and its application to a pharmacokinetic study. Journal of Liquid Chromatography and Related Technologies. 2018;41(10):692–7.
Pamu S, Subrahmanyam CS, Rao Patnaik KK. Bioanalytical method development and validation of valsartan in rabbit plasma. Int J Pharm. 2015;5(4):1360–4.
Venkatesh G, Majid MA, Ramanathan S, Mansor SM, Nair NK, Croft SL, et al. optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study. Biomedical Chromatography. 2008;22(5):535–41.
Vikas A, Rashmin P, Mrunali P, Sandip M, Kaushik T. RP-HPLC method for quantitative estimation of efinaconazole in topical microemulsion and microemulsion-based-gel formulations and in presence of its degradation products. Microchemical Journal. 2020;155:1-7.
Sura RS, Subrahmanyam CS, Rachamalla SS. Bioanalytical RP-HPLC method development and validation of clopidogrel bisulfate in wistar rat plasma and its application to pharmacokinetic study. International Journal of Applied Pharmaceutics. 2022;14(1):106–11.
Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS). Drug Development and Industrial Pharmacy. 2007;33(12):1318–26.
Garg NK, Sharma G, Singh B, Nirbhavane P, Katare OP. Quality by design (QbD)-based development and optimization of a simple, robust RP-HPLC method for the estimation of methotrexate. Journal of Liquid Chromatography and Related Technologies. 2015;38(17):1629–37.
Reddy CS, Rao BT. Development and validation of a stability-indicating related substances of trandolapril by RP-HPLC and its degradation. International Journal of Applied Pharmaceutics. 2021;13(5):115–21.
Kapoor B, Gupta R, Gulati M, Singh SK, Khatik GL, Chawla M, et al. High-performance liquid chromatography and liquid chromatography/mass spectrometry studies on stress degradation behavior of sulfapyridine and development of a validated, specific, stability-indicating HPLC assay method. Assay and Drug Development Technologies. 2020;18(3):119–33.
Kumar R, Kumar R, Khursheed R, Awasthi A, Khurana N, Singh SK, et al. Development and validation of RP-HPLC method for estimation of fisetin in rat plasma. South African Journal of Botany. 2021;140:284–9.
Devi PR, Rambabu K. Rapid determination of carboplatin and docetaxel using RP-HPLC with PDA detector. International Journal of Applied Pharmaceutics. 2022;14(2):186–92.
How to Cite
Copyright (c) 2022 RAMANKIT JAISWAL, RITA WADETWAR
This work is licensed under a Creative Commons Attribution 4.0 International License.